Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity

Aging Cell

Volumn 13, Issue 4, 2014, Pages 769-771

  Milman, Sofiya ^a   Atzmon, Gil ^a   Huffman, Derek M ^a   Wan, Junxiang ^b   Crandall, Jill P ^a   Cohen, Pinchas ^b   Barzilai, Nir ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cancer; Human; IGF 1; Insulin like growth factor 1; Longevity; Mortality

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SOMATOMEDIN C;

AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIFE EXPECTANCY; LONGEVITY; MALE; MEDICAL HISTORY; MORTALITY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; SURVIVAL; SURVIVAL TIME; DISEASE COURSE; KAPLAN MEIER METHOD; METABOLISM; PHYSIOLOGY; VERY ELDERLY;

ANIMALIA;

AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KAPLAN-MEIER ESTIMATE; LONGEVITY; MALE; SURVIVAL ANALYSIS;

EID: 84905045240     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/acel.12213     Document Type: Article

References (11)

1. Andersen SL, Sebastiani P, Dworkis DA, Feldman L, Perls TT (2012) Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span. J. Gerontol. A Biol. Sci. Med. Sci. 67, 395-405.
2. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A (1996) Dwarf mice and the ageing process. Nature 384, 33.
3. CDC/NCHS, National Vital Statistics System (2010) http://www.cdc.gov/nchs/data/hus/hus10.pdf [accessed on 10 October 2013].
4. Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, Wei M, Madia F, Cheng CW, Hwang D, Martin-Montalvo A, Saavedra J, Ingles S, de Cabo R, Cohen P, Longo VD (2011) Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci. Transl. Med. 3, 70ra13.
5. Ikeno Y, Bronson RT, Hubbard GB, Lee S, Bartke A (2003) Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevity. J. Gerontol. A Biol. Sci. Med. Sci. 58, 291-296.
6. Kaplan RC, Buzkova P, Cappola AR, Strickler HD, McGinn AP, Mercer LD, Arnold AM, Pollak MN, Newman AB (2012) Decline in circulating insulin-like growth factors and mortality in older adults: cardiovascular health study all-stars study. J. Clin. Endocrinol. Metab. 97, 1970-1976.
7. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R (1993) A C. elegans mutant that lives twice as long as wild type. Nature 366, 461-464.
8. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363, 1346-1353.
9. Roubenoff R, Parise H, Payette HA, Abad LW, D'Agostino R, Jacques PF, Wilson PW, Dinarello CA, Harris TB (2003) Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am. J. Med. 115, 429-435.
10. Sonntag WE, Csiszar A, deCabo R, Ferrucci L, Ungvari Z (2012) Diverse roles of growth hormone and insulin-like growth factor-1 in mammalian aging: progress and controversies. J. Gerontol. A Biol. Sci. Med. Sci. 67, 587-598.
11. Suh Y, Atzmon G, Cho MO, Hwang D, Liu B, Leahy DJ, Barzilai N, Cohen P (2008) Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc. Natl Acad. Sci. USA 105, 3438-3442.